Danahy Kevin Patrick's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Sep 22, 2025
- Accession no.
- 0001437749-25-029646
- Filed
- Sep 22, 2025
- Trade date
- Sep 18-19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $377.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Danahy Kevin PatrickCIK 0001913245 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $1.53 | +$30,600 | 63,298 | Direct | |
| Sep 18, 2025 | Common Stock | SSaleDisposed | −20,000 | $18.49F2 | −$369,800 | 43,298 | Direct | |
| Sep 19, 2025 | Common Stock | MOption exerciseAcquired | +400 | $1.53 | +$612 | 43,698 | Direct | |
| Sep 19, 2025 | Common Stock | SSaleDisposed | −400 | $18.48 | −$7,392 | 43,298 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 430,000 | Direct | |
| Sep 19, 2025 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 429,600 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $19.48 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.